title: Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity.
abstract: Gangliosides shed by tumors enhance tumor formation, possibly by suppressing host antitumor immune function, and gangliosides purified from animal tissues and cultured cells inhibit human cellular immune function in vitro. Determination of immunosuppressive activity of highly purified gangliosides, to uncover structure-activity relationships, is therefore important. Here we have studied a series of gangliosides obtained from human tissue and determined their effects on human natural killer (NK) activity. Total gangliosides from human brain tissue were moderately inhibitory; 100 nmol/ml reduced NK activity of human nonadherent PBMC by 43%. The influence of carbohydrate structure upon inhibitory activity was determined by study of eight highly (HPLC) purified individual gangliosides. Of these, we unexpectedly found that the two minor brain gangliosides with the simplest carbohydrate structures, GM2 and GM3, were very active inhibitors (75 and 47%, respectively, at 50 nmol/ml). In contrast, the structurally more complex major species, GM1, GD1a, GD1b, GT1b, and two other minor gangliosides, GD2 and GD3, were inactive. Reduced effector-target binding in a single-cell binding assay by GM2 but not GM3 suggests different mechanisms of inhibition by these two active gangliosides. Since GM2 and GM3 are present in high concentrations in, and are shed by, several common human tumors (e.g., neuroblastoma, melanoma, and glioma), their ability to inhibit NK cytotoxicity supports the hypothesis of a role of shed tumor gangliosides in the enhancement of tumor formation.
authors.affiliation: Department of Pediatrics, UCLA School of Medicine 90024.
authors.forename: G
authors.initials: G
authors.lastname: Grayson
authors.forename: S
authors.initials: S
authors.lastname: Ladisch
mesh_terms: D001923:Brain Chemistry; D002240:Carbohydrate Sequence; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005732:Gangliosides / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007113:Immunity, Innate / Q000187:drug effects*; D066298:In Vitro Techniques; D007694:Killer Cells, Natural / Q000276:immunology*; D008969:Molecular Sequence Data; D013329:Structure-Activity Relationship
chemical_list: D005732:Gangliosides